NAGE vs WST: fair value comparison
Niagen Bioscience, Inc. and West Pharmaceutical Services, Inc. · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, NAGE currently sits closer to the top of our discount ranking. WST carries the stronger quality grade.
| NAGE | WST | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $3.53 | $337.47 |
| 12-month range | $3.33–$9.88 | $237.50–$347.94 |
| Sector rank | #62 of 113 Healthcare | #63 of 113 Healthcare |
| Quality grade | C | B |
| Momentum grade | — | A |
| Leverage | Low | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: NAGE fair value analysis · WST fair value analysis